Global Bioinformatics Platforms Market Research Report
- Report Code: BI 1000
- Publish Date: Upcoming
The global bioinformatics platform market was valued at $901.0 million in 2013, and expected to reach $3.6 billion by 2018, at a CAGR of 22.0% from 2012 to 2018. The growth in this market is attributed to the increasing funding in this sector by government and private organizations.
The report ‘The Global Bioinformatics Platform Market forecast, 2012-2018’ analyzes the bioinformatics platform market by segments, such as sequence alignment, structural analysis, sequence analysis, and sequence manipulation platform. The sequence analysis platform market segment has accounted for the largest share of the overall bioinformatics platform market, due to increasing development of high-through-put sequencing technologies.
North America is the global leader in the bioinformatics platform market, followed by Europe and Asia. Dominant in the U.S. and Europe, the market is increasing steadily, due to increasing application of bioinformatics in both biotechnological and pharmaceutical research. Decreasing costs of DNA analysis in the last few years is the major driver for the bioinformatics platform market. Increase in the number of complete genomes is further accelerating the growth, whereas, lack of standardization is a restraint for the market.
The report also provides an extensive competitive landscaping of companies operating in the bioinformatics platform market include Pacific Biosciences, Illumina Inc., PerkinElmer Inc., Life Technologies Corporation, and Roche Applied Sciences.
Segment and country-specific company shares, news & deals, M&A, segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report.
Customization Options
Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep-dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment-wise)
- Product matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment-wise and country-wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Procedure Volume Data
- Number of laboratories, research institutes, and universities where the bioinformatics platform products are installed
Researchers Perception analysis
- Fast turn-around analysis of researchers’ response to market events and trends
- Pattern analysis of usage of bioinformatics platforms by researchers’ opinion about products from different companies
Brand/Product Perception Matrix
- Comprehensive study of customers’ perception and behavior through our in-built social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution
Competitive Intelligence
- Company share analysis of the bioinformatics market
- Crucial developments and strategies of companies inculcated in their portfolios
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Bioinformatics Platforms The North American Bioinformatics platform Market, by increasing funding by government and private organization, was pegged at $ 408 million in 2013 and expected to be $ 1.56 billion by 2018, growing at a CAGR of 21.1% from 2012 to 2018. The report “The North American Bioinformatics Platform Market forecast, 2012-2018” analyzes the Bioinformatics platform market into Sequence alignment, structural analysis, sequence analysis and sequence manipulation platforms. Bioinformatics platform market include Pacific Biosciences, Illumina Inc., PerkinElmer Inc., Life Technologies Corporation, and Roche Applied Sciences. |
Upcoming |
|
|
European Bioinformatics Platforms The European Bioinformatics platform Market, by increasing funding by government and private organization, was pegged at $ 227 million in 2013 and expected to be $ 847 million by 2018, growing at a CAGR of 20.7% from 2012 to 2018. The report “The European Bioinformatics Platform Market forecast, 2012-2018” analyzes the Bioinformatics platform market into Sequence alignment, structural analysis, sequence analysis and sequence manipulation platforms. The key players in European Bioinformatics platform market include Illumina Inc., PerkinElmer Inc., Life Technologies Corporation, and Roche Applied Sciences. |
Upcoming |
|
|
Asia-Pacific Bioinformatics Platforms The Asia-Pacific Bioinformatics platform Market, by increasing funding by government and private organization, was pegged at $ 175 million in 2013 and expected to be $ 831 million by 2018, growing at a CAGR of 24.9% from 2012 to 2018. The report “The Asia-Pacific Bioinformatics Platform Market forecast, 2012-2018” analyzes the Bioinformatics platform market into Sequence alignment, structural analysis, sequence analysis and sequence manipulation platforms. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics platform market include Illumina Inc., PerkinElmer Inc., Life Technologies Corporation, and Roche Applied Sciences. |
Upcoming |
